In PANC-1 pancreatic cancer cells, NPD11033 not only decreased cell proliferation but also increased the acetylation level of eIF5a, a SIRT2 deacetylation substrate (Kudo et al., 2018). The gene discussed is SIRT2; the disease is pancreatic neoplasm.